Vista Pharmaceuticals Ltd.
BSE: 524711 | Sector: Health care |
NSE: N.A. | ISIN Code: INE427C01021 |
BSE 00:00 | 23 May | 7.09 |
0.28 (4.11%) |
OPEN
6.95 |
HIGH
7.13 |
LOW
6.59 |
NSE 05:30 | 01 Jan | Vista Pharmaceuticals Ltd |
OPEN | 6.95 |
PREVIOUS CLOSE | 6.81 |
VOLUME | 13141 |
52-Week high | 15.97 |
52-Week low | 6.51 |
P/E | |
Mkt Cap.(Rs cr) | 26 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
Vista Pharmaceuticals Ltd. (VISTAPHARMA) - Announcements
-
Vista Pharmaceuticals Ltd Board Meeting Intimation for Approval Of Financial Results For The Quarter And Year Ended 31.03.2022
23/05/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2022
21/04/2022 | bse
-
Vista Pharmaceuticals Ltd Closure of Trading Window
31/03/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Financial Results For The Quarter Ended 3Lst December2021 - Regulation 33 (3) (A)
14/02/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Board Meeting Outcome for Approval Of Un-Audited Financial Results For The Quarter Ended 31St Decemb
14/02/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Board Meeting Intimation for Approval Of Un-Audited Financial Results For The Quarter Ended 31St Dec
07/02/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Shareholding for the Period Ended December 31 2021
19/01/2022 | bse
-
Vista Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
19/01/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
19/01/2022 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended December 2021
19/01/2022 | bse
-
Vista Pharmaceuticals Ltd Closure of Trading Window
30/12/2021 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Financial Results For The Quarter Ended 30Th September 2021 Regulation 33 (3) (A).
13/11/2021 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of Board Meeting - Regulation 30
13/11/2021 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Board Meeting Intimation for Intimation Of Board Meeting To Be Held On 13.11.2021.
06/11/2021 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Shareholding for the Period Ended September 30 2021
21/10/2021 | bse
-
Vista Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
21/10/2021 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended September 2021
21/10/2021 | bse
-
Vista Pharmaceuticals Ltd Closure of Trading Window
01/10/2021 | bse |
Downlaod PDF
-
Vista Pharmaceuticals Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations 2015)
27/09/2021 | bse
-
Vista Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Scrutinizers Report
27/09/2021 | bse |
Downlaod PDF
Quick Links for Vista Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices